[IO Summit 2022] Implementing MOA-Reflective ADCC & ADCP Cytotoxicity Assays Using Ready-to-Use KILR® Target & Effector Cells from Screening to Lot Release

[IO Summit 2022] Implementing MOA-Reflective ADCC & ADCP Cytotoxicity Assays Using Ready-to-Use KILR® Target & Effector Cells from Screening to Lot Release
File Name/Number:
IO Summit

Year:
2022

 

Jane E. Lamerdin, Ph.D.
Vice President, Research & Development
Eurofins DiscoverX